CausalSentinel

Protein Dossier — CD14 (Monocyte differentiation antigen CD14)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Systolic blood pressure automated reading -0.0216 0.00738 0.00335 Inverse variance weighted 2 trans NA
Systolic blood pressure automated reading -0.0216 0.00738 0.00335 Inverse variance weighted 2 cis NA
IgA nephropathy -0.585 0.235 0.0126 Inverse variance weighted 2 trans NA
IgA nephropathy -0.585 0.235 0.0126 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: R07 Pain in throat and chest -0.132 0.0568 0.0201 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R07 Pain in throat and chest -0.132 0.0568 0.0201 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: R11 Nausea and vomiting 0.212 0.0938 0.0238 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R11 Nausea and vomiting 0.212 0.0938 0.0238 Inverse variance weighted 2 cis NA
Lumbar spine bone mineral density -0.0586 0.0264 0.0265 Inverse variance weighted 2 trans NA
Lumbar spine bone mineral density -0.0586 0.0264 0.0265 Inverse variance weighted 2 cis NA
Parkinson’s disease -0.518 0.234 0.0272 Wald ratio 1 trans NA
Diagnoses - main ICD10: K29 Gastritis and duodenitis 0.0933 0.0426 0.0285 Inverse variance weighted 2 trans NA
…and 193 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

45 association rows across 27 traits (43 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Soluble CD14 levels 7e-124 rs75652866 3 GCST90093300 no MR -> candidate analysis
Monocyte differentiation antigen CD14 levels 2e-73 rs5744441 3 GCST90246929 no MR -> candidate analysis
CD14 protein levels 3e-68 rs190828983 4 GCST90468598 no MR -> candidate analysis
Height 2e-63 rs2569193 2 GCST90245848 MR: beta=-0.0593, p=0.11 (trans)
Monocyte differentiation antigen CD14, soluble levels 2e-52 rs5744454 3 GCST90249440 no MR -> candidate analysis
Cerebrospinal fluid protein CD14 levels 2e-46 rs2569193 1 GCST90944962 no MR -> candidate analysis
CPXM1/HBEGF protein level ratio 1e-27 rs778582 1 GCST90314219 no MR -> candidate analysis
Serum levels of protein CD14 6e-20 rs60745418 1 GCST90090416 no MR -> candidate analysis
HLA class II histocompatibility antigen, DR beta 3 chain lev 3e-16 rs778583 1 GCST90426852 no MR -> candidate analysis
Monocyte differentiation antigen CD14, soluble level in Chro 1e-15 rs75652866 1 GCST90234613 no MR -> candidate analysis
Monocyte differentiation antigen CD14 level in Chronic kidne 4e-14 rs5744451 1 GCST90239125 no MR -> candidate analysis
Body shape phenotype PC2 5e-14 rs2569178 1 GCST90832990 no MR -> candidate analysis
…and 15 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1347 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
gout 0.249 common-variant locus no MR -> candidate analysis
Back pain 0.223 common-variant locus no MR -> candidate analysis

Of the 2 rows above, 2 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (Monocyte differentiation antigen CD14)
gnomAD constraint pLI=0.0085, LOEUF=3.72 — LoF-tolerant
GWAS Catalog 72 unique SNPs / 144 rows
ClinVar 74 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance